Big Blue wants out of health care, after spending billions to stake its claim, just as rival Oracle is moving big into the sector via its $28 billion bet for Cerner. IBM spent more than $4 billion to build Watson Health via a series of acquisitions. The business now includes health care data and analytics business Truven Health Analytics, population health company Phytel, and medical imaging business Merge Healthcare. IBM first explored a sale of the division in early 2021, with Morgan Stanley leading the process. WSJ reported at the time that the unit was generating roughly $1 billion in annual revenue, but was unprofitable. Sources say it continues to lose money.

After Watson triumphed on the gameshow Jeopardy in 2011, its star scientist had to convince IBM that it wasn't a magic answer box, and "explained that Watson was engineered to identify word patterns and predict correct answers for the trivia game." The New York Times looks at what's happened in the decade since.

Watson has not remade any industries. And it hasn't lifted IBM's fortunes. The company trails rivals that emerged as the leaders in cloud computing and A.I. — Amazon, Microsoft and Google. While the shares of those three have multiplied in value many times, IBM's stock price is down more than 10 percent since Watson's "Jeopardy!" triumph in 2011. The company's missteps with Watson began with its early emphasis on big and difficult initiatives intended to generate both acclaim and sizable revenue for the company, according to many of the more than a dozen current and former IBM managers and scientists interviewed for this article.

IBM has released an open dataset of coding samples, which demonstrate programming tasks, to help train AI systems to write code. The dataset, known as Project CodeNet, includes 14 million code samples in 55 different programming languages. Researchers at IBM have already begun using the dataset to train AI systems to write code and found that the systems achieved a 90 percent accuracy rate in most code classification and code similarity experiments.

IBM CEO Arvind Krishna announced today that the company would no longer sell facial recognition services, calling for a “national dialogue” on whether it should be used at all.